RARE ULTRAGENYX PHARMACEUTICAL
Health Care · Russell 2000
Next earnings: not announced yet
What 24 analyst firms say about ULTRAGENYX PHARMACEUTICAL: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
26 rated views · 27 analyst/firm records · 24 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8039
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8036
Recent analyst activity · last 90 days
Our tracked history has 46 reports on RARE from 21 analyst firms in the last 90 days (24 firms in the past year).
Comparing each firm's latest target with its previous one: 5 raised their price target, 8 lowered it, 2 left it unchanged and 2 have their first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 3 downgrades.
Latest observed target change: Barclays lowered its target from $35.00 (set 21 Sep 2026) to $32.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Jack K Allen | Hold | 3 Sep 2026 | 16.00 USD |
| Baird | Joel Beatty | Hold | 3 Sep 2026 | 16.00 USD |
| Bank of America Securities | Unnamed analyst | Hold | 3 Sep 2026 | — |
| Barclays | Eliana Merle | Buy | 21 Sep 2026 | 35.00 USD |
| Canaccord Genuity | Whitney Ijem | Buy | 18 Sep 2026 | 39.00 USD |
| Cantor Fitzgerald | Kristen Kluska | Buy | 18 Sep 2026 | 39.00 USD |
| Citigroup | Yigal Nochomovitz | Buy | 18 Sep 2026 | 32.00 USD |
| Evercore ISI | Gavin Clark-Gartner | Hold | 2 Sep 2026 | 18.00 USD |
| Goldman Sachs | Salveen Richter | Hold | 4 Sep 2026 | 19.00 USD |
| Guggenheim | Debjit Chattopadhyay | Buy | 4 Aug 2026 | 35.00 USD |
| H.C. Wainwright | Raghuram Selvaraju | Buy | 3 Sep 2026 | 25.00 USD |
| Jefferies | Maury Raycroft | Buy | 3 Sep 2026 | 28.00 USD |
| JPMorgan | Anupam Rama | Hold | 3 Sep 2026 | 36.00 USD |
| Leerink Partners | Joseph P Schwartz | Buy | 2 Sep 2026 | 33.00 USD |
| Morgan Stanley | Maxwell Skor | Hold | 18 Sep 2026 | 20.00 USD |
| Piper Sandler | Allison M Bratzel | Buy | 17 Aug 2026 | — |
| RBC Capital Markets | Luca Issi | Hold | 3 Sep 2026 | 19.00 USD |
| TD Cowen | Yaron Werber | Buy | 3 Sep 2026 | 18.00 USD |
| Truist | Unnamed analyst | Buy | 25 Mar 2026 | — |
| UBS | Joon Lee | Hold | 15 Oct 2026 | 16.00 USD |
| Wedbush | Laura Chico | Hold | 3 Sep 2026 | 23.00 USD |
| Weiss Ratings | Unnamed analyst | — | 6 Oct 2026 | — |
| Wells Fargo | Benjamin Burnett | Hold | 3 Sep 2026 | 18.00 USD |
| Wells Fargo | Michael Turrin | Hold | 3 Sep 2026 | 18.00 USD |
| William Blair | Lachlan Hanbury-Brown | Hold | 23 Sep 2026 | — |
| William Blair | Sami Corwin | Hold | 23 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | 19.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:00 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.